Plain-English translation of NCT07126236 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to treat large B cell lymphoma that has come back after your first round of treatment. The medication works by recruiting your own immune cells to fight the cancer cells. Previous studies show it's effective and manageable, but doctors want to confirm it works well as a second-line treatment option for patients like you.
While this medication has shown promise in earlier studies, there is no solid evidence yet that it works as a second-line treatment for your type of lymphoma. This trial will provide that evidence and help doctors decide whether to offer this as an option instead of other available treatments.
You likely qualify if…
You likely don't qualify if…
You will receive the medication through infusions at a hospital or clinic. The study has two treatment options: some participants receive the medication alone for up to 12 cycles, while others receive it alone for 3 cycles, then combined with two additional medications for cycles 4 through 15. A treatment cycle typically lasts several weeks. You will have regular blood tests, scans, and clinic visits to monitor how you are responding and to watch for side effects.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Spain